Bupropion for ADHD
Bupropion can be used as a second-line treatment for ADHD when stimulants are ineffective, cause intolerable side effects, or when there are concerns about stimulant misuse, but stimulants remain the first-line treatment with superior efficacy. 1
Treatment Hierarchy
First-Line Treatment
- Stimulant medications (methylphenidate and amphetamine-based stimulants) are the gold standard for ADHD treatment, with 70-80% response rates. 2, 1
- Stimulants work rapidly, allowing assessment of ADHD symptom response within days. 2
- Methylphenidate is recommended at 5-20 mg three times daily for adults, while dextroamphetamine is dosed at 5 mg three times daily to 20 mg twice daily. 2
Second-Line: When to Consider Bupropion
Bupropion should be considered in the following clinical scenarios:
- When stimulants are ineffective or cause intolerable side effects 1
- When there are concerns about stimulant misuse or diversion 1
- In patients with comorbid depression where dual treatment may be beneficial 2
- In patients with substance abuse history where stimulants pose higher risk 2
Bupropion Efficacy Evidence
Symptom Improvement
- Bupropion decreases ADHD symptom severity with a standardized mean difference of -0.50 (95% CI -0.86 to -0.15), though this is based on low-quality evidence. 3
- The proportion of patients achieving clinical improvement increases by 50% compared to placebo (RR 1.50,95% CI 1.13 to 1.99). 3
- Clinical Global Impression-Improvement scores show 78% greater improvement with bupropion versus placebo (RR 1.78,95% CI 1.27 to 2.50). 3
- Head-to-head trials found bupropion had comparable efficacy to methylphenidate, though one large multicenter study found smaller effect sizes for bupropion than methylphenidate. 4
Comparative Effectiveness
While bupropion shows benefit, its effect sizes are smaller than stimulants, making it clearly a second-line option. 1, 4
Dosing Protocol
Sustained-Release (SR) Formulation
- Start at 100-150 mg daily 1
- Titrate to maintenance dose of 100-150 mg twice daily 1
- Titration should be gradual to minimize side effects 1
Extended-Release (XL) Formulation
- Start at 150 mg daily 1
- Titrate to maintenance dose of 150-300 mg daily 1
- Maximum dose: 450 mg daily 2, 1
Safety Considerations
Common Side Effects
- Headache, insomnia, and anxiety are notable side effects. 2
- The proportion of patients withdrawing due to adverse effects is similar between bupropion and placebo (RR 1.20,95% CI 0.35 to 4.10), indicating tolerability comparable to placebo. 3
Serious Risks
- Seizure risk increases, particularly at higher doses, and this risk is further elevated when combined with stimulants. 2
- Bupropion has a narrow therapeutic window with maximum daily dosing of 450 mg. 5
- Cardiotoxicity including QT prolongation can occur in overdose situations. 5
Drug Interactions
- Never use MAO inhibitors concurrently with bupropion due to risk of severe hypertension and potential cerebrovascular accidents. 2
- When combining with stimulants, careful monitoring for side effects is necessary, though no specific FDA warnings exist against this combination. 2
Special Populations
Pregnancy
- Bupropion may be considered as an alternative to stimulants during pregnancy, though it has been associated with a small increased risk of certain cardiovascular malformations with first-trimester exposure. 2
- Limited data suggests bupropion does not appear to be associated with major congenital malformations. 1
Substance Abuse History
- Bupropion is particularly useful in patients with substance abuse history where stimulants pose diversion or misuse concerns. 2, 1
- Long-acting stimulant formulations like Concerta may still be preferred over bupropion in this population due to lower abuse potential. 2
Comorbid Bipolar Disorder
- Bupropion may be effective for ADHD in adults with comorbid bipolar disorder without significant activation of mania, though this requires adjunct mood stabilizers. 6
Combination Therapy
Adding bupropion to stimulant medication may enhance ADHD symptom control when stimulants alone are inadequate, particularly when comorbid depressive symptoms exist. 2
- Start bupropion SR at 100-150 mg daily or XL at 150 mg daily when adding to existing stimulant therapy 2
- Monitor carefully for increased seizure risk with combination therapy 2
Critical Pitfall to Avoid
Do not assume bupropion will effectively treat both ADHD and depression simultaneously—no single antidepressant is proven for this dual purpose. 2 If ADHD symptoms improve on stimulants but mood symptoms persist, consider adding an SSRI to the stimulant regimen rather than switching to bupropion monotherapy. 2